Li Jianhua, Li Mengyu, Ge Yangyang, Chen Jiayi, Ma Jiamin, Wang Chenchen, Sun Miaomiao, Wang Li, Yao Shanglong, Yao Chengye
Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Cell Biosci. 2022 May 26;12(1):69. doi: 10.1186/s13578-022-00807-5.
Blood-brain barrier (BBB) dysfunction may occur at the onset of Alzheimer's disease (AD). Pericytes are a vital part of the neurovascular unit and the BBB, acting as gatekeepers of the BBB. Amyloid β (Aβ) deposition and neurofibrillary tangles in the brain are the central pathological features of AD. CD36 promotes vascular amyloid deposition and leads to vascular brain damage, neurovascular dysfunction, and cognitive deficits. However, the molecular mechanism by which pericytes of the BBB are disrupted remains unclear.
To investigate the effect of low-dose Aβ1-40 administration on pericyte outcome and the molecular mechanism of BBB injury.
We selected 6-month-old and 9-month-old APP/PS1 mice and wild-type (WT) mice of the same strain, age, and sex as controls. We assessed the BBB using PET/CT. Brain pericytes were extracted and cocultured with endothelial cells (bEnd.3) to generate an in vitro BBB model to observe the effect of Aβ1-40 on the BBB. Furthermore, we explored the intracellular degradation and related molecular mechanisms of Aβ1-40 in cells.
BBB permeability and the number of pericytes decreased in APP/PS1 mice. Aβ1-40 increased BBB permeability in an in vivo model and downregulated the expression of CD36, which reversed the Aβ-induced changes in BBB permeability. Aβ1-40 was uptaked in pericytes with high CD36 expression. We observed that this molecule inhibited pericyte proliferation, caused mitochondrial damage, and increased mitophagy. Finally, we confirmed that Aβ1-40 induced pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway.
PDGFRβ (a marker of pericytes), CD36, and Aβ colocalized in vitro and in vivo, and Aβ1-40 caused BBB disruption by upregulating CD36 expression in pericytes. The mechanism by which Aβ1-40 destroys the BBB involves the induction of pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway.
血脑屏障(BBB)功能障碍可能在阿尔茨海默病(AD)发病时出现。周细胞是神经血管单元和血脑屏障的重要组成部分,充当血脑屏障的守门人。大脑中的淀粉样β(Aβ)沉积和神经原纤维缠结是AD的核心病理特征。CD36促进血管淀粉样沉积,并导致血管性脑损伤、神经血管功能障碍和认知缺陷。然而,血脑屏障周细胞被破坏的分子机制仍不清楚。
研究低剂量Aβ1-40给药对周细胞结局的影响以及血脑屏障损伤的分子机制。
我们选择6个月大和9个月大的APP/PS1小鼠以及同品系、年龄和性别的野生型(WT)小鼠作为对照。我们使用PET/CT评估血脑屏障。提取脑周细胞并与内皮细胞(bEnd.3)共培养以建立体外血脑屏障模型,观察Aβ1-40对血脑屏障的影响。此外,我们探索了Aβ1-40在细胞内的降解及相关分子机制。
APP/PS1小鼠的血脑屏障通透性和周细胞数量减少。Aβ1-40在体内模型中增加了血脑屏障通透性,并下调了CD36的表达,这逆转了Aβ诱导的血脑屏障通透性变化。Aβ1-40在CD36高表达的周细胞中被摄取。我们观察到该分子抑制周细胞增殖,导致线粒体损伤,并增加线粒体自噬。最后,我们证实Aβ1-40通过CD36/PINK1/Parkin途径诱导周细胞线粒体自噬依赖性铁死亡。
血小板衍生生长因子受体β(PDGFRβ,周细胞标志物)、CD36和Aβ在体外和体内共定位,并且Aβ1-40通过上调周细胞中CD36的表达导致血脑屏障破坏。Aβ1-40破坏血脑屏障的机制涉及通过CD36/PINK1/Parkin途径诱导周细胞线粒体自噬依赖性铁死亡。